Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Annovis Bio
Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Kodiak Sciences
Kodiak is a biopharmaceutical company focused on developing transformative therapeutics to treat retinal diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Neuvivo
Neuvivo is a biopharmaceutical company developing a new treatment for ALS.
Sector
Subsector
Keywords
Location
total rounds
total raised
Sunovion Pharmaceuticals
Sunovion is a global biopharmaceutical company.
Sector
Subsector
Location
total rounds
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 24.01.2022. Their latest round Series B
Mountain Group Capital
Nashville's Mountain Group Partners invests in early-stage Life Sciences and Disruptive Technology.
Sector
Subsector
Location
count Of Investments
count Of Exists
Deerfield Capital Management
Deerfield Capital Management is a venture capital firm focused on healthcare investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors3
Number of lead investors
Number of investors
Deerfield
Deerfield is an investment management firm that specializes in healthcare investments, including information, investment, and philanthropy.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Mountain Group Capital
Nashville's Mountain Group Partners invests in early-stage Life Sciences and Disruptive Technology.
Sector
Subsector
Location
count Of Investments
count Of Exists
Joe Cook III
Prior to his involvement with MGC, Mr. Cook was a Director, Private Placements in the Investment Banking Group of Robert W. Baird & Co. in Nashville from January 2001 through February 2003. Mr. Cook, as head of Baird’s private placement group, was responsible for the private placement of equity and debt securities for both private and public companies. During these two years, Mr. Cook helped originate and led the team executing nine transactions raising almost $400 million. Previously, Mr. Cook was a Vice President in the Investment Banking Group at J.C. Bradford & Co. in Nashville. He joined Bradford in July 1993 as a financial analyst, working on initial and secondary public equity offerings, public debt offerings, mergers and acquisitions, and business valuations. From December 1995 through June 2000, he specialized in private finance, including leveraged buyouts and private debt and equity placements. Mr. Cook is past Chairman and board member of the Martha O’Bryan Center, and was a founding board member of Ten Thousand Villages of Nashville. Mr. Cook graduated with a B.A. in Economics from Davidson College, and moved to Nashville, TN in 1993. Mr. Cook co-founded Diagnovus and Device Innovation Group and sits on the boards of Pathfinder Therapeutics, VenX Medical, Industrial Ceramic Solutions, and DPS Healthcare. Via visitation rights he also actively participates on the boards of ABT Molecular Imaging and OnFocus Healthcare.
current job
Deerfield Capital Management
Deerfield Capital Management is a venture capital firm focused on healthcare investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
William Slattery
Bill is a Partner on the Private Transactions team at Deerfield, which he joined in 2000. He began his professional career studying immune system complications associated with End Stage Renal Disease. Prior to joining Deerfield, Bill was a senior healthcare analyst between 1990 and 2000 at Amerindo Investment Advisors overseeing biotechnology investments. He has held various positions in research including those at National Medical Enterprises, Johnson & Johnson, and HMSS. Bill has degrees in Biochemistry from State University of New York at Albany and completed Immunology graduate studies at the Graduate School-New Brunswick, Rutgers University.
current job
Howie Furst
Howie is a Partner on the Biotech team at Deerfield and a physician with 11 years of clinical experience. Howie joined Deerfield in 2007 and provides extensive research and analysis on individual companies operating in the healthcare industry. Previously, at Magnetar Capital, Howie’s mandate as Portfolio Manager was to build out the firm’s healthcare team and develop its private and public investment approach. Before joining Magnetar, Howie served as a life sciences analyst at Maverick Capital. Among his other accomplishments in his six years there, he founded the firm’s healthcare venture capital efforts and structured a number of transactions. Howie received his B.A. with honors from the University of Pennsylvania and his M.D. from New York University.
current job
People
Founders1
Brian Laden
Dr. Laden is a Co-founder and Partner at TriStar Technology Ventures, a venture capital investment group currently managing two early stage healthcare-focused funds totaling approximately $40 million. TriStar Technology Ventures is a part of the Healthcare Investment Group, consisting of three healthcare-focused investment funds with approximately $1 billion under management. With a primary focus across the life sciences, including medical devices, diagnostics and drug discovery, he sits on the Board of five portfolio companies and actively oversees TriStar’s interest in two others. Dr. Laden is also a founding director of Vertex Clinical Innovations, a company that provides technology transfer services to hospitals, health systems and universities. Prior to co-founding TriStar and Vertex, he served as the Assistant Director in the Office of Technology Transfer and Enterprise Development at Vanderbilt University. He is also active in the Association of University Technology Managers (AUTM), previously serving as the Associate Vice President and a member of the Board of Directors. Prior to moving into technology transfer, Dr. Laden worked as a postdoctoral researcher in the Department of Biochemistry at Vanderbilt, where his work focused on structure-function studies of the cytochromes P450. He holds a doctorate in Toxicology from the University of Kentucky, a Master’s degree in Environmental and Industrial Health from the University of Michigan and an undergraduate degree in Biology from Penn State University.
current job
Brian Laden
